Paolo Tarantino/X
Apr 25, 2025, 12:33
Paolo Tarantino: Two practice-changing ADC phase 3 trials announced to be positive
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“2025 is “ADC year”.
Two practice-changing ADC phase 3 trials announced to be positive.
At least 6 more may read out this year, likely leading to further changes in the treatment of breast cancer. Exciting times.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 08:02
Sep 8, 2025, 07:51
Sep 8, 2025, 07:43
Sep 8, 2025, 07:33
Sep 8, 2025, 07:27
Sep 8, 2025, 07:17
Sep 8, 2025, 07:07